Menopause & midlife

Hormone Pellets: Why Guidelines Urge Caution

Save

Hormone pellets, implanted under the skin, often deliver higher-than-normal levels of estrogen or testosterone and cannot be adjusted or easily removed once placed. Most are custom-compounded and skip FDA testing, and major menopause and endocrine societies advise against them. Regulated, adjustable hormone options exist for menopause symptoms.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What are hormone pellets?

Hormone pellets are small compressed cylinders of estrogen, testosterone, or both, placed under the skin of the hip during a minor in-office procedure. They dissolve slowly and are usually reinserted every 3 to 6 months.

Most pellets are custom-compounded rather than FDA-approved, which means their exact dose and release rate are not standardized or tested 1. Clinics often market them as convenient and natural, but the Menopause Society groups compounded pellets with other preparations it does not recommend for routine menopause care 1. The convenience is real; the trade-off is control over the dose, which the next sections explain.

Why do guidelines worry about the dose?

Pellets often push hormone levels above what the body would make on its own. For testosterone in particular, the Global Consensus Position Statement, endorsed by the Endocrine Society and the International Menopause Society, advises against pellets and injections precisely because they can produce supraphysiologic, higher-than-normal blood concentrations 2.

That statement holds that the only evidence-based reason to use testosterone in women is postmenopausal low sexual desire, at doses that approximate normal premenopausal levels, with blood monitoring 2. Pellets make that fine control difficult. Estrogen pellets raise a parallel concern, since a fixed implant cannot flex to a person's changing needs, and blood levels can stay elevated for weeks after the dose is set 2.

What happens if a side effect appears?

Once a pellet is under the skin, the dose cannot be dialed down, and removing it means another procedure to extract it. That matters because high hormone levels can cause unpredictable spotting, breast tenderness, acne, or, with testosterone, unwanted hair growth and voice changes that may not fully reverse.

According to ACOG, compounded hormone preparations lack the standardized dosing and safety data of approved products, which makes troubleshooting side effects harder 3. With a patch, gel, or pill, a clinician can lower the dose or pause therapy within 1 to 2 days; a pellet locks in its release for the full 3 to 6 months. That is why guidelines frame the missing off-switch, not the hormone itself, as the core problem 3. Reviewing your menopause symptoms helps weigh whether that trade-off is worth it.

What do major societies recommend?

Leading menopause and endocrine groups converge on caution. The Menopause Society and an Endocrine Society guideline both steer patients toward regulated, adjustable products rather than compounded pellets 14.

Menopause itself usually arrives between ages 45 and 55, and hormone needs shift across that transition and beyond, according to the World Health Organization, another reason a fixed, months-long implant sits awkwardly with changing physiology 5. For most women, the same symptoms pellets promise to fix, including hot flashes, night sweats, and mood or sleep changes in perimenopause, respond to tested therapies whose dose can be tuned 4. Regulated, adjustable therapy also fits the benefit window for healthy women under 60 or within 10 years of menopause 1.

When hormone pellet questions need a menopause specialist

A menopause or endocrine specialist can compare regulated, dose-adjustable hormone replacement therapy with pellets and explain the evidence behind each 1. If you already have pellets and are having side effects, a clinician can help you manage them and plan next steps until the implant wears off over the next few months 3.

Because pellets cannot be fine-tuned, the choice is best made before insertion, with your full history in view. That way a fixed, months-long dose is weighed against a patch, gel, or pill you can adjust week to week 4. Gale can help you prepare that conversation.

Common questions

Most pellets used for menopause are custom-compounded and are not FDA-approved, so their dose and release rate are not standardized. FDA-approved patches, gels, pills, and vaginal products are regulated alternatives.

Not easily. Once placed, a pellet keeps releasing hormone for months, and removing it requires a second procedure. That lack of an off-switch is a main reason societies urge caution.

A pellet delivers a fixed amount that cannot flex to your needs, and testosterone pellets in particular can raise blood levels above the normal range. Guidelines cite these supraphysiologic levels as a safety concern.

Regulated hormone therapy, including transdermal estradiol, oral or micronized progesterone, and low-dose vaginal estrogen, can be adjusted or paused as needed. A clinician can match the form to your symptoms and history.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Pellet warning signs worth acting on

  • —Deepening voice, rapid hair growth, or severe acne after a testosterone pellet is a reason to seek clinician review, as these can signal supraphysiologic levels.
  • —Heavy or unexplained vaginal bleeding, or any bleeding after menopause, is a reason to arrange prompt evaluation.
  • —A hot, red, or painful lump at the insertion site is a reason to seek same-day clinician review for possible infection.
  • —Sudden leg swelling, calf pain, or shortness of breath warrants urgent medical care to rule out a blood clot.

This article is general health education, not medical advice. Whether any hormone therapy fits you, and whether pellets are appropriate, should be decided with a gynecologist, menopause, or endocrine clinician.

References

  1. 1.The North American Menopause Society (Menopause Society) (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000002028 ✓The 2022 Menopause Society position statement that compounded pellet therapy is not recommended for routine menopause care, that regulated adjustable products are preferred, and that benefits generally outweigh risks for healthy women under 60 or within 10 years of menopause.
  2. 2.Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019). Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Clinical Endocrinology & Metabolism. doi:10.1210/jc.2019-01603 ✓The Global Consensus Position Statement on testosterone therapy for women, endorsed by the Endocrine Society and International Menopause Society, advising against pellets and injections because they can produce supraphysiologic levels, and limiting the evidence-based indication to postmenopausal low sexual desire with blood monitoring.
  3. 3.American College of Obstetricians and Gynecologists (2014). ACOG Practice Bulletin No. 141: management of menopausal symptoms. Obstetrics & Gynecology. doi:10.1097/01.AOG.0000441353.20693.78 ✓ACOG guidance that compounded hormone preparations lack the standardized dosing and safety data of approved products, complicating management of side effects.
  4. 4.Stuenkel CA, et al. (Endocrine Society) (2015). Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. doi:10.1210/jc.2015-2236 ✓Endocrine Society clinical practice guideline steering patients toward regulated, dose-adjustable hormone therapies for menopausal symptoms rather than compounded pellets.
  5. 5.World Health Organization (2024). Menopause (fact sheet). World Health Organization (WHO). link ✓WHO fact sheet that natural menopause usually occurs between ages 45 and 55 and that hormone needs shift across the transition, supporting the case for adjustable therapy.

5 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library